Clinical trials
Completed Emphysema trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
106 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 3 |
| 2003 | 1 |
| 2004 | 5 |
| 2005 | 3 |
| 2006 | 7 |
| 2007 | 11 |
| 2008 | 4 |
| 2009 | 14 |
| 2010 | 2 |
| 2011 | 6 |
| 2012 | 6 |
| 2013 | 6 |
| 2014 | 6 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 5 |
| 2018 | 7 |
| 2019 | 4 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 106 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 10 |
| Aeris Therapeutics | 5 |
| GlaxoSmithKline | 5 |
| Mayo Clinic | 5 |
| Sumitomo Pharma America, Inc. | 5 |
| University of Pittsburgh | 5 |
| Weill Medical College of Cornell University | 4 |
| Columbia University | 3 |
| Olympus Corporation of the Americas | 3 |
| VA Office of Research and Development | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Emphysema | 106 |
| Pulmonary Disease, Chronic Obstructive | 89 |
| Bronchitis, Chronic | 33 |
| Lung Diseases | 14 |
| alpha 1-Antitrypsin Deficiency | 13 |
| Asthma | 6 |
| Bronchitis | 6 |
| Pulmonary Emphysema | 6 |
| HIV Infections | 5 |
| Cystic Fibrosis | 3 |
Trials
Showing 1 to 25 of 106. Each trial links to its page on Pharma Observatory.
6 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.